COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
Guardado en:
Autores principales: | Eftychios Siniorakis, Spyridon Arvanitakis, Ioannis Nikolopoulos, Maximilianos Elkouris |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49018571ed5340da8e1b55ce34b70433 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: David S. Fedson, et al.
Publicado: (2020) -
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019) -
Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Davide Stolfo, et al.
Publicado: (2019) -
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
por: Susanne Rysz, et al.
Publicado: (2021) -
The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19
por: George El-Arif, et al.
Publicado: (2021)